STUDY OBJECTIVES: To examine whether subjective sleep quality and sleep duration moderate the association between age and telomere length (TL). DESIGN: Participants completed a demographic and sleep quality questionnaire, followed by a blood draw. SETTING: Social Neuroscience Laboratory. PARTICIPANTS: One hundred fifty-four middle-aged to older adults (age 45-77 y) participated. Participants were excluded if they were on immunosuppressive treatment and/or had a disease with a clear immunologic (e.g., cancer) component. INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: Subjective sleep quality and sleep duration were assessed using the Pittsburgh Sleep Quality Index (PSQI) and TL was determined using peripheral blood mononuclear cells (PBMCs). There was a significant first-order negative association between age and TL. Age was also negatively associated with the self-reported sleep quality item and sleep duration component of the PSQI. A significant age × self-reported sleep quality interaction revealed that age was more strongly related to TL among poor sleepers, and that good sleep quality attenuated the association between age and TL. Moreover, adequate subjective sleep duration among older adults (i.e. greater than 7 h per night) was associated with TL comparable to that in middle-aged adults, whereas sleep duration was unrelated to TL for the middle-aged adults in our study. CONCLUSIONS: The current study provides evidence for an association between sleep quality, sleep duration, and cellular aging. Among older adults, better subjective sleep quality was associated with the extent of cellular aging, suggesting that sleep duration and sleep quality may be added to a growing list of modifiable behaviors associated with the adverse effects of aging.
STUDY OBJECTIVES: To examine whether subjective sleep quality and sleep duration moderate the association between age and telomere length (TL). DESIGN:Participants completed a demographic and sleep quality questionnaire, followed by a blood draw. SETTING: Social Neuroscience Laboratory. PARTICIPANTS: One hundred fifty-four middle-aged to older adults (age 45-77 y) participated. Participants were excluded if they were on immunosuppressive treatment and/or had a disease with a clear immunologic (e.g., cancer) component. INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: Subjective sleep quality and sleep duration were assessed using the Pittsburgh Sleep Quality Index (PSQI) and TL was determined using peripheral blood mononuclear cells (PBMCs). There was a significant first-order negative association between age and TL. Age was also negatively associated with the self-reported sleep quality item and sleep duration component of the PSQI. A significant age × self-reported sleep quality interaction revealed that age was more strongly related to TL among poor sleepers, and that good sleep quality attenuated the association between age and TL. Moreover, adequate subjective sleep duration among older adults (i.e. greater than 7 h per night) was associated with TL comparable to that in middle-aged adults, whereas sleep duration was unrelated to TL for the middle-aged adults in our study. CONCLUSIONS: The current study provides evidence for an association between sleep quality, sleep duration, and cellular aging. Among older adults, better subjective sleep quality was associated with the extent of cellular aging, suggesting that sleep duration and sleep quality may be added to a growing list of modifiable behaviors associated with the adverse effects of aging.
Authors: Christina S McCrae; Meredeth A Rowe; Candece G Tierney; Natalie D Dautovich; Allison L Definis; Joseph P H McNamara Journal: J Gerontol B Psychol Sci Soc Sci Date: 2005-07 Impact factor: 4.077
Authors: Janet M Mullington; Norah S Simpson; Hans K Meier-Ewert; Monika Haack Journal: Best Pract Res Clin Endocrinol Metab Date: 2010-10 Impact factor: 4.690
Authors: Hans K Meier-Ewert; Paul M Ridker; Nader Rifai; Meredith M Regan; Nick J Price; David F Dinges; Janet M Mullington Journal: J Am Coll Cardiol Date: 2004-02-18 Impact factor: 24.094
Authors: Christopher Ryan King; Kristen L Knutson; Paul J Rathouz; Steve Sidney; Kiang Liu; Diane S Lauderdale Journal: JAMA Date: 2008-12-24 Impact factor: 56.272
Authors: Marta Jackowska; Mark Hamer; Livia A Carvalho; Jorge D Erusalimsky; Lee Butcher; Andrew Steptoe Journal: PLoS One Date: 2012-10-29 Impact factor: 3.240
Authors: Judith E Carroll; Michael R Irwin; Morgan Levine; Teresa E Seeman; Devin Absher; Themistocles Assimes; Steve Horvath Journal: Biol Psychiatry Date: 2016-07-26 Impact factor: 13.382
Authors: Laurie Grieshober; Jean Wactawski-Wende; Rachael Hageman Blair; Lina Mu; Jingmin Liu; Jing Nie; Cara L Carty; Lauren Hale; Candyce H Kroenke; Andrea Z LaCroix; Alex P Reiner; Heather M Ochs-Balcom Journal: Am J Epidemiol Date: 2019-09-01 Impact factor: 4.897
Authors: Judith E Carroll; Stephanie Esquivel; Alyssa Goldberg; Teresa E Seeman; Rita B Effros; Jeffrey Dock; Richard Olmstead; Elizabeth C Breen; Michael R Irwin Journal: Sleep Date: 2016-03-01 Impact factor: 5.849
Authors: Aric A Prather; Blake Gurfein; Patricia Moran; Jennifer Daubenmier; Michael Acree; Peter Bacchetti; Elizabeth Sinclair; Jue Lin; Elizabeth Blackburn; Frederick M Hecht; Elissa S Epel Journal: Brain Behav Immun Date: 2014-12-20 Impact factor: 7.217
Authors: Judith E Carroll; Steven W Cole; Teresa E Seeman; Elizabeth C Breen; Tuff Witarama; Jesusa M G Arevalo; Jeffrey Ma; Michael R Irwin Journal: Brain Behav Immun Date: 2015-08-31 Impact factor: 7.217